Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive RNA sequencing in primary murine keratinocytes and fibroblasts identifies novel biomarkers and provides potential therapeutic targets for skin-related diseases. | Cell Mol Biol Lett | 2021 | 34602061 | PubTator, text mining | PubMed |
| Intermittent Hypoxia Upregulates the Renin and Cd38 mRNAs in Renin-Producing Cells via the Downregulation of miR-203. | Int J Mol Sci | 2021 | 34576290 | PubTator, text mining | PubMed |
| Star-PAP RNA Binding Landscape Reveals Novel Role of Star-PAP in mRNA Metabolism That Requires RBM10-RNA Association. | Int J Mol Sci | 2021 | 34576144 | PubTator, text mining | PubMed |
| Drugs Interfering with Insulin Resistance and Their Influence on the Associated Hypermetabolic State in Severe Burns: A Narrative Review. | Int J Mol Sci | 2021 | 34575946 | PubTator, text mining | PubMed |
| Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells. | Cancers (Basel) | 2021 | 34572782 | PubTator, text mining | PubMed |
| Transcriptional Landscaping Identifies a Beige Adipocyte Depot in the Newborn Mouse. | Cells | 2021 | 34572017 | PubTator, text mining | PubMed |
| Biologia Futura: is ADAM 17 the reason for COVID-19 susceptibility in hyperglycemic and diabetic patients? | Biol Futur | 2021 | 34554559 | PubTator, text mining | PubMed |
| Multi-omic Analysis of Non-human Primate Heart after Partial-body Radiation with Minimal Bone Marrow Sparing. | Health Phys | 2021 | 34546217 | PubTator, text mining | PubMed |
| Role of protein phosphatase 2A in kidney disease (Review). | Exp Ther Med | 2021 | 34539832 | PubTator, text mining | PubMed |
| The Effect of Local Renin Angiotensin System in the Common Types of Cancer. | Front Endocrinol (Lausanne) | 2021 | 34539580 | PubTator, text mining | PubMed |
| Editorial: Neuroprotection in Synaptic Signalling During Neurological Disorders. | Front Synaptic Neurosci | 2021 | 34539374 | PubTator, text mining | PubMed |
| Inhibition of DNA methylation in newborns reprograms ischemia-sensitive biomarkers resulting in development of a heart ischemia-sensitive phenotype late in life. | Reprod Toxicol | 2021 | 34536542 | PubTator, text mining | PubMed |
| Effect of Tension on Human Periodontal Ligament Cells: Systematic Review and Network Analysis. | Front Bioeng Biotechnol | 2021 | 34513810 | PubTator, text mining | PubMed |
| SARS-CoV-2 and the Eyes: A Review of the Literature on Transmission, Detection, and Ocular Manifestations. | Med Sci Monit | 2021 | 34508064 | PubTator, text mining | PubMed |
| Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors. | Int J Mol Sci | 2021 | 34502113 | PubTator, text mining | PubMed |
| Computational Prediction of Compound-Protein Interactions for Orphan Targets Using CGBVS. | Molecules | 2021 | 34500569 | PubTator, text mining | PubMed |
| An Ovarian Cancer Susceptible Gene Prediction Method Based on Deep Learning Methods. | Front Cell Dev Biol | 2021 | 34485310 | PubTator, text mining | PubMed |
| Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs. | Biomed Pharmacother | 2021 | 34479017 | PubTator, text mining | PubMed |
| Rare and intractable fibrodysplasia ossificans progressiva shows different PBMC phenotype possibly modulated by ascorbic acid and propranolol treatment. | Intractable Rare Dis Res | 2021 | 34466340 | PubTator, text mining | PubMed |
| Immunomodulation and immunotherapeutics of COVID-19. | Clin Immunol | 2021 | 34461289 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=26